Estrogen patch vs pill vs gel: which HRT form is safer?

Name: Estrogen patch vs pill vs gel: which HRT form is safer?
Creator: MenoWoman

Estrogen pills, patches and gels all treat hot flashes, but pills carry a higher risk of blood clots than estrogen through the skin. Guidelines say a patch, gel or spray at standard doses does not raise clot risk above normal, which is why it is often suggested for women at higher risk.

Researched by the MenoWoman team. Edited by Marcela Sat. Updated 7 November 2026. We may earn from links.

Get urgent help for a painful, swollen leg, sudden chest pain or shortness of breath, or signs of stroke such as face drooping or slurred speech. See a doctor about bleeding after menopause, unexpected or heavy bleeding on HRT, a new breast lump, or a rash that does not settle where you apply HRT.

The main forms of estrogen

Estrogen for whole-body (systemic) treatment comes as pills, skin patches, gels, sprays, creams and some vaginal rings.⁴ These forms all treat hot flashes and other menopause symptoms.

Oral estrogen (pill): swallowed and absorbed through the gut, then processed by the liver.
Transdermal estrogen: absorbed through the skin. This includes patches, gels and sprays.
Vaginal estrogen: low-dose creams, tablets or rings for vaginal and urinary symptoms only.⁴ See vaginal estrogen.

If you still have a womb, estrogen is usually combined with a progestogen to protect the womb lining. This applies to every systemic form.⁴ In the UK, this is called HRT, and oestrogen is the UK spelling.

HRT is not a contraceptive, and pregnancy is still possible in perimenopause. NICE advises that women in perimenopause are given information about contraception.¹

Transdermal vs oral estrogen: blood clot risk

NICE, the guideline body for England, says oral HRT raises the risk of blood clots in the veins (venous thromboembolism, or VTE). Transdermal HRT at standard doses carries a risk no greater than in women not using HRT.¹

NICE advises considering transdermal rather than oral HRT for women at higher clot risk, including those with a BMI over 30.¹ For women at high risk, such as those with an inherited clotting disorder, it suggests a specialist blood assessment first.¹

The Menopause Society's 2022 statement agrees that transdermal routes and lower doses may lower the risk of VTE and stroke. It says dose, regimen and route should be chosen for each woman.²

A large UK study published in 2019 compared about 80,000 women with clots against about 390,000 without. Oral HRT was linked to higher clot risk (odds ratio 1.58). Transdermal HRT was not linked to added risk.³ Among pills, estradiol carried a lower risk than conjugated equine estrogen.³ This was an observational study, so it shows a link, not proof of cause.

HRT gel vs patch

Gels, sprays and patches are all transdermal, and guidelines treat them together when they discuss clot risk.¹ The choice between them is often practical.

Patches stick to the skin and release estrogen steadily. Some people prefer not having to apply anything daily. Patches come as estrogen-only or combined with a progestogen.⁵
Gels and sprays are applied to the skin and left to dry. Some people prefer them if a patch irritates their skin or will not stay on. They contain estrogen only, so a separate progestogen is needed if you have a womb.⁵

No guideline ranks gels above patches or the reverse. The British Menopause Society notes that absorption varies a lot between individuals, so doses of different products cannot be matched exactly.⁵ If side effects appear, changing the route is one option it lists for prescribers.⁵

Your prescriber explains how to use whichever form you are given, and you can ask to switch if one does not suit you.

Other things to weigh

Overall HRT risk depends more on age, time since menopause, the type and dose of hormone, and personal health history than on the form alone.^2,4 Starting systemic HRT at 60 or older, or more than 10 years after menopause, carries more risk of serious problems.⁴

Pills may suit women who prefer them, and cost and stock vary by country. Some forms may be unavailable or not covered by insurance where you live. A doctor can help you weigh these with your own risks. Read more on hormone therapy.

What it is used for: evidence rated

Option	Evidence	What the research shows
Estrogen pill (oral)	Strong evidence	Treats hot flashes and other symptoms. Raises blood clot risk above baseline, more than skin forms.^1,3,4
Estrogen patch (transdermal)	Strong evidence	Treats hot flashes and other symptoms. Guidelines and a large observational study show no added clot risk at standard doses; no large trial has compared clot risk directly with pills.^1,2,3
Estrogen gel or spray (transdermal)	Strong evidence	Treats hot flashes and other symptoms. NICE groups it with patches as transdermal, with clot risk no greater than baseline at standard doses.^1,2
Low-dose vaginal estrogen	Strong evidence	Treats vaginal and urinary symptoms with less absorption than systemic forms; not for hot flashes.⁴

Ratings explained: how we rate. Always talk to a doctor or pharmacist before starting a medicine or supplement.